Collegium Pharma Elects New Directors, Adjusts Officer Compensation
Ticker: COLL · Form: 8-K · Filed: Mar 17, 2025 · CIK: 1267565
| Field | Detail |
|---|---|
| Company | Collegium Pharmaceutical, Inc (COLL) |
| Form Type | 8-K |
| Filed Date | Mar 17, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-of-directors, executive-compensation, governance
TL;DR
Board shakeup at Collegium Pharma: two new directors in, exec pay details out.
AI Summary
Collegium Pharmaceutical, Inc. announced on March 11, 2025, a change in its board of directors. Specifically, the company elected two new directors, Dr. Andrew K. C. Chang and Ms. Jennifer L. Mcneal, to its Board of Directors, effective immediately. This filing also disclosed compensatory arrangements for certain officers.
Why It Matters
Changes in board composition can signal shifts in strategic direction or governance, while adjustments to executive compensation may impact future financial performance and shareholder value.
Risk Assessment
Risk Level: medium — Board changes and executive compensation adjustments can introduce uncertainty and potential shifts in company strategy.
Key Players & Entities
- Collegium Pharmaceutical, Inc. (company) — Registrant
- Dr. Andrew K. C. Chang (person) — Newly Elected Director
- Ms. Jennifer L. Mcneal (person) — Newly Elected Director
- March 11, 2025 (date) — Effective date of director election
FAQ
Who were the new directors elected to Collegium Pharmaceutical's Board?
Dr. Andrew K. C. Chang and Ms. Jennifer L. Mcneal were elected as new directors.
When were the new directors elected?
The new directors were elected effective March 11, 2025.
What other information was disclosed in this 8-K filing?
The filing also disclosed compensatory arrangements of certain officers.
What is Collegium Pharmaceutical's principal executive office address?
The principal executive offices are located at 100 Technology Center Drive, Suite 300, Stoughton, MA 02072.
What is the Commission File Number for Collegium Pharmaceutical?
The Commission File Number is 001-37372.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 17, 2025 by Dr. Andrew K. C. Chang regarding COLLEGIUM PHARMACEUTICAL, INC (COLL).